» Articles » PMID: 37222701

Gene Editing and Scalable Functional Genomic Screening in Species Using the CRISPR/Cas9 Cytosine Base Editor Toolbox LeishBASEedit

Overview
Journal Elife
Specialty Biology
Date 2023 May 24
PMID 37222701
Authors
Affiliations
Soon will be listed here.
Abstract

CRISPR/Cas9 gene editing has revolutionised loss-of-function experiments in , the causative agent of leishmaniasis. As lack a functional non-homologous DNA end joining pathway however, obtaining null mutants typically requires additional donor DNA, selection of drug resistance-associated edits or time-consuming isolation of clones. Genome-wide loss-of-function screens across different conditions and across multiple species are therefore unfeasible at present. Here, we report a CRISPR/Cas9 cytosine base editor (CBE) toolbox that overcomes these limitations. We employed CBEs in to introduce STOP codons by converting cytosine into thymine and created http://www.leishbaseedit.net/ for CBE primer design in kinetoplastids. Through reporter assays and by targeting single- and multi-copy genes in , , , and , we demonstrate how this tool can efficiently generate functional null mutants by expressing just one single-guide RNA, reaching up to 100% editing rate in non-clonal populations. We then generated a -optimised CBE and successfully targeted an essential gene in a plasmid library delivered loss-of-function screen in . Since our method does not require DNA double-strand breaks, homologous recombination, donor DNA, or isolation of clones, we believe that this enables for the first time functional genetic screens in via delivery of plasmid libraries.

Citing Articles

Improved base editing and functional screening in via co-expression of the AsCas12a ultra variant, a T7 RNA polymerase, and a cytosine base editor.

Herrmann May N, Cao A, Schmid A, Link F, Arias-Del-Angel J, Meiser E Elife. 2025; 13.

PMID: 39991929 PMC: 11850003. DOI: 10.7554/eLife.97437.


Evidence for gene essentiality in Leishmania using CRISPR.

Zhang W, Matlashewski G PLoS One. 2025; 19(12):e0316331.

PMID: 39775585 PMC: 11684651. DOI: 10.1371/journal.pone.0316331.


CRISPR-Cas9 high-throughput screening to study drug resistance in .

Queffeulou M, Leprohon P, Fernandez-Prada C, Ouellette M, Mejia-Jaramillo A mBio. 2024; 15(7):e0047724.

PMID: 38864609 PMC: 11253630. DOI: 10.1128/mbio.00477-24.


Transforming the CRISPR/dCas9-based gene regulation technique into a forward screening tool in .

Lucky A, Wang C, Li X, Liang X, Muneer A, Miao J iScience. 2024; 27(4):109602.

PMID: 38617559 PMC: 11015506. DOI: 10.1016/j.isci.2024.109602.


Recent Advances in CRISPR/Cas9-Mediated Genome Editing in Leishmania Strains.

Abdi Ghavidel A, Aghamiri S, Raee P, Mohammadi-Yeganeh S, Noori E, Bandehpour M Acta Parasitol. 2023; 69(1):121-134.

PMID: 38127288 DOI: 10.1007/s11686-023-00756-0.

References
1.
de Paiva R, Grazielle-Silva V, Cardoso M, Nakagaki B, Mendonca-Neto R, Canavaci A . Amastin Knockdown in Leishmania braziliensis Affects Parasite-Macrophage Interaction and Results in Impaired Viability of Intracellular Amastigotes. PLoS Pathog. 2015; 11(12):e1005296. PMC: 4671664. DOI: 10.1371/journal.ppat.1005296. View

2.
Brettmann E, Shaik J, Zangger H, Lye L, Kuhlmann F, Akopyants N . Tilting the balance between RNA interference and replication eradicates Leishmania RNA virus 1 and mitigates the inflammatory response. Proc Natl Acad Sci U S A. 2016; 113(43):11998-12005. PMC: 5087061. DOI: 10.1073/pnas.1615085113. View

3.
MAGA J, Sherwin T, Francis S, Gull K, Lebowitz J . Genetic dissection of the Leishmania paraflagellar rod, a unique flagellar cytoskeleton structure. J Cell Sci. 1999; 112 ( Pt 16):2753-63. DOI: 10.1242/jcs.112.16.2753. View

4.
Lye L, Owens K, Shi H, Murta S, Vieira A, Turco S . Retention and loss of RNA interference pathways in trypanosomatid protozoans. PLoS Pathog. 2010; 6(10):e1001161. PMC: 2965760. DOI: 10.1371/journal.ppat.1001161. View

5.
Fenoy I, Bogado S, Contreras S, Gottifredi V, Angel S . The Knowns Unknowns: Exploring the Homologous Recombination Repair Pathway in Toxoplasma gondii. Front Microbiol. 2016; 7:627. PMC: 4853372. DOI: 10.3389/fmicb.2016.00627. View